
Triomics
Triomics is a YC Winter 2021 (W21) company. Based in San Francisco, CA, USA. Team of 50.
About Triomics
Summary
Triomics builds oncology-specific AI agents that read unstructured patient records, notes, reports, and faxes, then deliver structured, cited outputs directly into cancer center workflows. The product replaces manual chart review by clinicians and coordinators at cancer centers and life sciences teams, covering jobs such as clinical trial screening, cancer registry maintenance, and visit preparation.
Business model
Pricing terms are not public.
Go-to-market
Cancer centers and life sciences companies are the primary buyers, reached through a sales-led motion with a demo booking entry point.
From the Y Combinator listing
Generative AI for Oncology EHRs
Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.
Facts
- Healthcare / Healthcare -> Healthcare Services
- San Francisco, CA, USA
- 50
- Active
- Growth
Founders (2)
- Sarim Khan
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works